Failure of erythropoietin to render jeopardized ischemic myocardium amenable to incremental salvage by early reperfusion

Objectives Erythropoietin (EPO) has been thought to be capable of potentiating protection of jeopardized myocardium by reperfusion in evolving myocardial infarction. However, diversity in study design and measurements of infarct size in studies evaluating EPO has led to inconsistent results. We sought to characterize the effect of EPO on infarct size after myocardial ischemia and reperfusion with the use of assessment of left-ventricular (LV) creatine kinase (CK) depletion and echocardiography. Methods Acute coronary occlusion was induced in 10-week-old C57BL6 mice by left anterior descending coronary artery ligation for 3 h followed by 72 h of reperfusion. EPO (10000 U/kg) or an equivalent amount of saline vehicle alone was injected intraperitoneally before ligation or immediately after the onset of reperfusion. Assays of residual LV CK activity and calculation of LV CK depletion were performed on LV homogenates harvested 72 h after onset of reperfusion for measurement of infarct size, and echocardiography was performed immediately before harvest of tissue for measurement of function. Results Mice administered EPO before ligation had similar infarct size (37.1 +/- 4.1%) and echo scores (22.9 +/- 0.4) compared with those in corresponding control mice administered saline (35.29 +/- 1.9 and 21.3 +/- 1.1%, respectively). Mice administered EPO after reperfusion had similar infarct size (39.1 +/- 4.8%) and echo scores (19.5 +/- 1.0) compared with those in corresponding control mice administered saline (40.3 +/- 4.9 and 21.5 +/- 1.9%, respectively). Conclusion EPO does not protect ischemic myocardium such that reperfusion after 3 h can yield additional salvage. Coron Artery Dis 20:295-299 (C) 2009 Wolters Kluwer Health | Lippincott Williams & Wilkins.